By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on both Oklo and NuScale, highlighting shared risks such as regulatory hurdles, fuel supply chain constraints, and uncertain timelines for nuclear projects. Neither company has yet delivered a commercial reactor, and both face significant execution risks.
Risk: Fuel supply chain constraints (HALEU bottleneck) and uncertain project timelines
Opportunity: NuScale's regulatory moat (certification advantage) if fuel supply chains tighten
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Oklo has $2.5 billion in cash and marketable securities, giving the nuclear energy company a substantial runway.
NuScale is the only small modular reactor maker with design approval from the Nuclear Regulatory Commission.
There's no doubt that nuclear power will play a crucial role in meeting the world's energy needs over the next several years. Two small modular reactor (SMR) companies, Oklo (NYSE: OKLO) and NuScale Power (NYSE: SMR), are pre- and early-revenue businesses that won't be profitable for quite some time. So which one is actually worth buying right now?
Oklo has seen significant price swings, driven mainly by strong enthusiasm and prospects. Oklo has a strong balance sheet despite not yet generating revenue from its technology. The company has $2.5 billion in cash and no debt. Because of this, Oklo has the runway it needs to succeed.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Oklo is targeting the end of 2027 for the deployment of its Aurora microreactor, which will serve data centers and industrial facilities.
NuScale's competitive advantage lies in being the only SMR company with design certification from the U.S. Nuclear Regulatory Commission. There is one significant problem hanging over NuScale's head, however. The company is facing a class action lawsuit alleging it misled investors regarding its partnership with ENTRA1 Energy.
ENTRA1 is a private company that collaborates with NuScale. The lawsuit alleges that NuScale exaggerated ENTRA1's experience and capabilities to investors. The lawsuit is ongoing.
As of this writing, NuScale's stock has plunged nearly 30% year to date. Oklo's stock is also down more than 20% in the same time, but it has still increased by 40% over the past 12 months.
Both stocks still require a very high level of risk tolerance and a meaningful time horizon. Right now, Oklo is the cleaner bet and winner. It has a long runway and high-profile partners, including Meta Platforms.
NuScale had a regulatory lead, but the questions surrounding its legal issues make investing in the company too risky at the moment. If NuScale can beat the allegations with minimal financial and reputational damage, the company could still be quite successful in the coming years.
Before you buy stock in Oklo, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oklo wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $477,813! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,320,088!
Now, it’s worth noting Stock Advisor’s total average return is 986% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 25, 2026. *
Catie Hogan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Meta Platforms. The Motley Fool recommends NuScale Power. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Oklo's cash advantage is real but insufficient to offset its lack of regulatory certification and unproven deployment timeline."
The article correctly flags Oklo's $2.5B cash pile and zero debt as giving it more time than NuScale, yet it underplays how little that cash solves actual deployment hurdles. Oklo still lacks NRC design approval for its Aurora unit and targets first power only in late 2027, a timeline nuclear projects routinely miss. NuScale's existing certification and the ENTRA1 lawsuit are both material, but the regulatory edge is harder to replicate than balance-sheet runway. High-profile data-center interest helps both names, yet neither has booked firm, revenue-generating orders that de-risk the story. Investors are paying for optionality on AI-driven power demand rather than near-term cash flow.
Oklo's balance sheet and Meta tie-up could still let it leapfrog NuScale if regulatory approval arrives faster than expected and the lawsuit drags NuScale into prolonged uncertainty.
"Cash on the balance sheet is not the same as a path to profitability; both companies are pre-revenue and face binary execution risk, making the choice between them less important than the question of whether either deserves a venture-stage valuation in a public market."
The article frames this as Oklo-vs-NuScale, but both are pre-revenue bets on unproven technology with massive execution risk. Oklo's $2.5B cash is real, but it's also a burn-rate clock—at typical nuclear development spend, that's maybe 5-7 years of runway, not infinite. NuScale's NRC approval is genuinely valuable, but the ENTRA1 lawsuit isn't just reputational noise; if it reveals material misrepresentation to investors or regulators, it could trigger NRC re-review. The article's conclusion—'Oklo is the cleaner bet'—conflates balance sheet strength with technology viability. Neither company has delivered a commercial reactor yet. The real risk: both could fail, or both could succeed but at timelines that destroy equity holders through dilution.
Oklo's cash advantage evaporates if its Aurora microreactor hits unexpected regulatory or engineering delays—which is the base case for first-of-a-kind nuclear hardware, not the exception. NuScale's lawsuit could be noise; if dismissed or settled cheaply, its NRC certification becomes a durable moat that Oklo doesn't have.
"Oklo's cash-rich balance sheet is being conflated with project viability, ignoring the extreme regulatory and engineering risks inherent in their unproven reactor design."
The article's focus on Oklo's $2.5 billion cash position is misleading; it ignores the massive capital expenditure required for nuclear licensing and construction. While Oklo (OKLO) has significant backing, the regulatory hurdle—specifically the NRC’s stringent review process for non-light water reactors—is a multi-year bottleneck that cash alone cannot bypass. NuScale (SMR), despite its legal headwinds, possesses the only certified design, which is a structural moat in a highly regulated industry. Investors are currently overvaluing Oklo’s 'runway' while underestimating the execution risk of their fast-fission technology. Both are speculative, but Oklo’s valuation currently prices in success that is years away from reality.
The counter-argument is that NRC certification is a 'sunk cost' for NuScale that has yet to translate into profitable commercial deployment, whereas Oklo’s design is more aligned with the specific power density needs of AI hyperscalers.
"The real risk is timing and execution: regulatory milestones don’t guarantee revenue, and a legal dispute plus deployment delays could erase near-term upside for both Oklo and NuScale."
Oklo’s large cash pile vs NuScale’s NRC design certification creates a contrast between liquidity runway and regulatory moat. Yet neither is close to meaningful revenue in the near term, and SMR timelines are highly uncertain due to siting, financing, and customer demand. NuScale faces a class-action risk tied to ENTRA1 that could sap capital and tarnish credibility, while Oklo’s value hinges on eventual deployment (Aurora) rather than proven performance. The article glosses over deployment headwinds and assumes a favorable 2027 timeline, but real-world nuclear projects frequently slip, making the equity risk highly skewed to ultra-long horizons.
NuScale’s NRC certification could translate into real deployments and a credible revenue path if ENTRA1 proves credible; the lawsuit might be noise that investors over-interpret.
"HALEU fuel supply constraints could delay both companies beyond cash or certification advantages."
Gemini highlights NuScale's certification moat but misses the shared HALEU uranium bottleneck; US enrichment capacity remains years behind demand, and any Russia-related sanctions tightening would push first power past 2027 for Oklo's Aurora and NuScale alike. Cash runway and regulatory approval both become secondary if fuel supply chains cannot scale in time, a risk the article and panel have not addressed.
"HALEU scarcity makes NuScale's LEU-compatible design a structural advantage Oklo cannot overcome with cash alone."
Grok's HALEU bottleneck is the blindspot everyone missed, but it cuts both ways unevenly. Oklo's Aurora runs on HALEU; NuScale's SMR can use conventional LEU. If enrichment capacity stays constrained through 2028–2029, Oklo faces a hard stop that cash cannot solve, while NuScale's regulatory moat actually becomes more valuable because it can deploy sooner with existing fuel. This flips the risk calculus entirely—NuScale's certification advantage compounds if supply chains tighten.
"The ability to secure data center PPAs and manage physical construction logistics is a greater determinant of success than the specific fuel type or current regulatory status."
Claude is right about the HALEU bottleneck, but both of you are missing the 'hyperscaler' variable. Meta and others aren't buying reactors; they are buying power purchase agreements (PPAs) to secure grid priority. If Oklo’s design is better suited for behind-the-meter data center integration, they win the PPA race regardless of the fuel type. The real risk isn't just fuel or certification—it's whether these firms can actually build the infrastructure on time, which is a labor and supply chain crisis.
"HALEU fuel supply constraints could be the decisive constraint that erodes both Oklo’s and NuScale’s near-term timelines, regardless of cash or certification."
Grok, you are right about NuScale’s certification moat, but you repeatedly miss the HALEU bottleneck as a binary constraint. If HALEU supply remains tight through 2028–29, Oklo’s Aurora becomes a non-starter regardless of cash runway, and NuScale’s LEU path still needs scalable enrichment and fleets. The risk isn't just timing but fuel resilience—who can commit to fuel supply and site readiness in a seven-year horizon? That should compress both firms’ equity case.
The panel consensus is bearish on both Oklo and NuScale, highlighting shared risks such as regulatory hurdles, fuel supply chain constraints, and uncertain timelines for nuclear projects. Neither company has yet delivered a commercial reactor, and both face significant execution risks.
NuScale's regulatory moat (certification advantage) if fuel supply chains tighten
Fuel supply chain constraints (HALEU bottleneck) and uncertain project timelines